HEMATOPOIETIC/LYMPHOID CANCER
Clinical trials for HEMATOPOIETIC/LYMPHOID CANCER explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC/LYMPHOID CANCER trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC/LYMPHOID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon tested in fight against tough cancers
Disease control OngoingThis early-stage study is testing a new drug, ICT01, in people with advanced cancers that have come back or stopped responding to other treatments. Researchers want to see if ICT01 is safe, both on its own and when combined with an existing immunotherapy drug (Keytruda). They wil…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC